4-trimethylammonio-butyrates as cpt2 inhibitors

C - Chemistry – Metallurgy – 07 – C

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07C 233/51 (2006.01) A61K 31/197 (2006.01) A61K 31/381 (2006.01) A61P 3/06 (2006.01) A61P 3/08 (2006.01) A61P 9/12 (2006.01) C07C 235/12 (2006.01) C07C 237/12 (2006.01) C07D 213/55 (2006.01) C07D 333/24 (2006.01)

Patent

CA 2722114

This invention relates to novel4-trimethylammoniobutyrates of the formula wherein A1, R1, m and n are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof. These compounds inhibit carnitine palmitoyl transferase (CPT) activity, in particular CPT2 activity, and can be used as medicaments.

Cette invention concerne de nouveaux 4-triméthylammonio-butyrates de formule (I), dans laquelle A1, R1, m et n sont tels que définis dans la description et dans les revendications, et leurs sels pharmaceutiquement acceptables. Ces composés inhibent l'activité de la carnitine palmitoyltransférase (CPT), notamment l'activité de CPT2, et peuvent être utilisés comme médicaments.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

4-trimethylammonio-butyrates as cpt2 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 4-trimethylammonio-butyrates as cpt2 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-trimethylammonio-butyrates as cpt2 inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1862611

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.